Transcatheter Versus Surgical Aortic-Valve Replacement in High-Risk Patients
Craig R. Smith(University of Arizona), Stuart Pocock(London School of Hygiene & Tropical Medicine), William N. Anderson(Edwards Lifesciences (United States)), Vasilis Babaliaros(Valve (United States)), E. Murat Tuzcu(Cleveland Clinic), Michael J. Mack(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), D. Craig Miller(Harvard University), Duolao Wang(Guangdong Medical College), Lars G. Svensson(Cleveland Clinic), John G. Webb(St. Paul's Hospital), Todd Dewey(Medical City Dallas Hospital), Raj Makkar(Cedars-Sinai Medical Center), Mathew William(Cedars-Sinai Medical Center), Jeffrey W. Moses(Good Samaritan University Hospital), Jodi J. Akin(Edwards Lifesciences (United States)), Howard C. Herrmann(University of Pennsylvania), Gregory P. Fontana(HCA Healthcare), Samir Kapadia(Cleveland Clinic), Martin B. Leon(Columbia University Irving Medical Center), Paul J. Corso(MedStar Washington Hospital Center), Vinod H. Thourani(Valve (United States)), Augusto D. Pichard(MedStar Washington Hospital Center), Joseph E. Bavaria(University of Pennsylvania)
Cited by 645
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k